DU-125530 is a 5-HT1A receptor antagonist potentially for the treatment of anxiety, depression and psychiatric disorders. Through research, it has shown to improve clinical antidepressant effects by preferentially interacting with 5-HT(1A) autoreceptors. References: Scorza MC, Lladó-Pelfort L, Oller S, Cortés R, Puigdemont D, Portella MJ, Pérez-Egea R, Alvarez E, Celada P, Pérez V, Artigas F. Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment. Br J Pharmacol. 2012 Nov;167(5):1021-34. doi: 10.1111/j.1476-5381.2011.01770.x. PubMed PMID: 22050051; PubMed Central PMCID: PMC3492984.

纯度：≥98%

CAS：161611-99-0